COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02714608
Recruitment Status : Unknown
Verified March 2016 by Tasly Pharmaceuticals, Inc..
Recruitment status was:  Recruiting
First Posted : March 21, 2016
Last Update Posted : March 21, 2017
Information provided by (Responsible Party):
Tasly Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : May 2018
Estimated Study Completion Date : December 2018